U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C23H29NO3
Molecular Weight 367.4813
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENOPERIDINE

SMILES

CCOC(=O)C1(CCN(CCC(O)C2=CC=CC=C2)CC1)C3=CC=CC=C3

InChI

InChIKey=IPOPQVVNCFQFRK-UHFFFAOYSA-N
InChI=1S/C23H29NO3/c1-2-27-22(26)23(20-11-7-4-8-12-20)14-17-24(18-15-23)16-13-21(25)19-9-5-3-6-10-19/h3-12,21,25H,2,13-18H2,1H3

HIDE SMILES / InChI

Molecular Formula C23H29NO3
Molecular Weight 367.4813
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

PHENOPERIDINE is an opioid analgesic partly metabolized to meperidine in the liver. It is derived from pethidine by replacing the N methyl by a phenyl propanol chain. It is reputed to be a typical morphine-like analgesic characterized by its high potency, rapid onset of action, the intensity of its peak effect and the short duration of its pharmacological effects. It is used in general anesthesia.

Approval Year

AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1330 ng × min/mL
2 mg single, intravenous
dose: 2 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENOPERIDINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
193 min
2 mg single, intravenous
dose: 2 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENOPERIDINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
21.17%
15 μg/kg bw single, intravenous
dose: 15 μg/kg bw
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENOPERIDINE plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
2 mg single, intravenous
Studied dose
Dose: 2 mg
Route: intravenous
Route: single
Dose: 2 mg
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
2009-04-29
Contemporary strategies to preserve renal function during cardiac and vascular surgery.
2003
Motor neuropathy associated with cimetidine.
1980-10-11
Patents

Patents

Substance Class Chemical
Created
by admin
on Wed Apr 02 08:28:13 GMT 2025
Edited
by admin
on Wed Apr 02 08:28:13 GMT 2025
Record UNII
G9BH09J4JW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IDS-NP-010
Preferred Name English
PHENOPERIDINE
INN   MI   WHO-DD  
INN  
Official Name English
phenoperidine [INN]
Common Name English
DL-PHENOPERIDINE
Common Name English
R 1406
Code English
ISONIPECOTIC ACID, 1-(3-HYDROXY-3-PHENYLPROPYL)-4-PHENYL-, ETHYL ESTER
Systematic Name English
FENOPERIDINA
Common Name English
PHENOPERIDINE [MI]
Common Name English
NIH 7591
Code English
Phenoperidine [WHO-DD]
Common Name English
FENOPERIDINE
Common Name English
NIH-7591
Code English
R-1406
Code English
1-(3-HYDROXY-3-PHENYLPROPYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER
Systematic Name English
Classification Tree Code System Code
WHO-ATC N01AH04
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
WHO-VATC QN01AH04
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
NCI_THESAURUS C1506
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
NCI_THESAURUS C241
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
DEA NO. 9641
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C72123
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
DRUG BANK
DB13605
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
SMS_ID
100000082259
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105385
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
EPA CompTox
DTXSID90862199
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-229-2
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
RXCUI
8143
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY RxNorm
MESH
D010638
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
FDA UNII
G9BH09J4JW
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
CAS
562-26-5
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
PUBCHEM
11226
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
WIKIPEDIA
PHENOPERIDINE
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
INN
1062
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
MERCK INDEX
m8632
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
3441
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
EVMPD
SUB09775MIG
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
PRIMARY
CAS
66584-15-4
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
SUPERSEDED
CAS
55125-88-7
Created by admin on Wed Apr 02 08:28:13 GMT 2025 , Edited by admin on Wed Apr 02 08:28:13 GMT 2025
SUPERSEDED
Related Record Type Details
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
Related Record Type Details
ACTIVE MOIETY